For CCC, 5‐year survival was more than 20% lower for women with tumor block expression of p16 (45.2%, SE 5.0%) compared to heterogeneous staining (67.0%, SE 2.2%, p < 0.0001, Figure 1E). Here, CDKN2A is linked to neoplasm.